Form 8-K - Current report:
SEC Accession No. 0000950170-23-049919
Filing Date
2023-09-26
Accepted
2023-09-26 16:05:10
Documents
14
Period of Report
2023-09-20
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glto-20230920.htm   iXBRL 8-K 83661
2 EX-99.1 glto-ex99_1.htm EX-99.1 22800
3 GRAPHIC img80419653_0.jpg GRAPHIC 5036
  Complete submission text file 0000950170-23-049919.txt   243627

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glto-20230920.xsd EX-101.SCH 2449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glto-20230920_pre.xml EX-101.PRE 11420
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glto-20230920_lab.xml EX-101.LAB 14084
8 EXTRACTED XBRL INSTANCE DOCUMENT glto-20230920_htm.xml XML 4875
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 231280497
SIC: 2834 Pharmaceutical Preparations